Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)

China · Delayed Price · Currency is CNY

94.42

-1.87 (-1.94%)

Feb 13, 2026, 3:00 PM CST

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2018	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '18 Dec 31, 2018	Dec '16 Dec 31, 2016
Pharmaceuticals	531.53M
Pharmaceuticals Growth	38.58%
Technical Services	21.60M
Pharmaceutical Intermediates and Raw Materials	1.33M
Pharmaceutical Intermediates and Raw Materials Growth	-52.46%
Asset Licensing	91.74K
Asset Licensing Growth	20.00%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2018	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '18 Dec 31, 2018	Dec '16 Dec 31, 2016
China	532.95M
China Growth	37.91%